Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIZATRIPTAN vs ROLAPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIZATRIPTAN vs ROLAPITANT: Safety Overview

Metric RIZATRIPTAN ROLAPITANT
Total FAERS Reports 2,896 873
Deaths Reported 68 252
Death Rate 2.3% 28.9%
Hospitalizations 479 155
Average Patient Age 44.6 yrs 61.4 yrs
% Female Patients 77.2% 57.5%
FDA Approval Date Apr 14, 2023 Oct 25, 2017
Manufacturer Panacea Biotec Limited TerSera Therapeutics LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription